Article

Answering four key questions about HTA market archetypes

How understanding the nuances can help biopharma companies succeed
Chelsey Campbell, Director, Global Consulting, explains why biopharma companies must understand the commonly established HTA market archetypes to better impact the commercialization process. Enter your information below to learn more.

Pardot Form

Related resources

Newsletter

HTA Quarterly Summer 2026

Article

Rare diseases and orphan drugs: Assessing the PV implications

Article

AI-assisted quality assessment in HEOR: What works, what doesn’t, and how to apply GenAI responsibly